CompareMarketResearchRequest a sample
Home / Healthcare / Syringe

Healthcare · Market report

Syringe Market Size, Share and Forecast 2026-2036

The global syringe market is worth USD 21.2 bn in 2026 and is forecast to reach USD 39.8 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Conventional disposable is the largest by product segment.

USD 21.2 bnMarket size 2026
USD 39.8 bnForecast 2036
6.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global syringe market is worth USD 21.2 bn in 2026 and is forecast to reach USD 39.8 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Conventional disposable is the largest by product segment.

ScopeHypodermic and prefilled syringes used to inject medicines and vaccines: conventional disposable, safety, prefilled glass and plastic, and reusable specialty syringes.
IndustryHealthcare
Value 2025USD 20.0 bn
Value 2026USD 21.2 bn
Value 2036USD 39.8 bn
CAGR 2026-20366.5%
Volume 202647,463 million units
Volume 203684,759 million units
Average price 2026USD 0.45 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Syringe market size and forecast, 2026-2036

Exhibit 1The global syringe market is forecast to grow from USD 21.2 bn in 2026 to USD 39.8 bn by 2036, a rise of 88%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.5%
Syringe market value, 2025 to 2036Market value by year. 2025: USD 20.0 bn; 2026: USD 21.2 bn; 2027: USD 22.6 bn; 2028: USD 24.0 bn; 2029: USD 25.6 bn; 2030: USD 27.3 bn; 2031: USD 29.0 bn; 2032: USD 30.9 bn; 2033: USD 32.9 bn; 2034: USD 35.1 bn; 2035: USD 37.4 bn; 2036: USD 39.8 bn. Compound annual growth rate 2026 to 2036: 6.5%.202521.2 bn202629.0 bn203139.8 bn20366.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 21.2 bn
2027USD 22.6 bn
2028USD 24.0 bn
2029USD 25.6 bn
2030USD 27.3 bn
2031USD 29.0 bn
2032USD 30.9 bn
2033USD 32.9 bn
2034USD 35.1 bn
2035USD 37.4 bn
2036USD 39.8 bn

Syringe market segmentation

By product

Exhibit 2Conventional disposable is the largest segment by product, with 40.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Syringe market share by product, 2026Share of 2026 revenue by product. Conventional disposable: 40.0%; Prefilled syringes: 30.0%; Safety syringes: 20.0%; Reusable and specialty: 10.0%.Conventional disposable40.0%Prefilled syringes30.0%Safety syringes20.0%Reusable and specialty10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Conventional disposable40.0%29.6%USD 8.5 bn3.3%
Safety syringes20.0%22.6%USD 4.2 bn7.8%
Prefilled syringes30.0%40.8%USD 6.4 bn9.8%
Reusable and specialty10.0%7.0%USD 2.1 bn2.8%

By application

Exhibit 3Biologic and therapeutic injection adds the most revenue by application, growing from USD 5.9 bn in 2026 to USD 14.1 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Syringe market by application, 2026 and 2036Revenue by application in 2026 and 2036. Biologic and therapeutic injection: USD 5.9 bn in 2026, USD 14.1 bn in 2036, change +137%; General medication: USD 5.9 bn in 2026, USD 8.8 bn in 2036, change +48%; Vaccination: USD 4.7 bn in 2026, USD 8.4 bn in 2036, change +79%; Insulin and diabetes: USD 3.0 bn in 2026, USD 5.8 bn in 2036, change +97%; Dental and aesthetic: USD 1.7 bn in 2026, USD 2.8 bn in 2036, change +63%.20262036 forecastChangeBiologic and therapeutic injection+137%5.9 bn14.1 bnGeneral medication+48%5.9 bn8.8 bnVaccination+79%4.7 bn8.4 bnInsulin and diabetes+97%3.0 bn5.8 bnDental and aesthetic+63%1.7 bn2.8 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Vaccination22.0%21.0%USD 4.7 bn6.0%
Insulin and diabetes14.0%14.7%USD 3.0 bn7.0%
Biologic and therapeutic injection28.0%35.3%USD 5.9 bn9.0%
Dental and aesthetic8.0%6.9%USD 1.7 bn5.0%
General medication28.0%22.1%USD 5.9 bn4.0%

By size

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Up to 3 ml56.0%55.0%USD 11.9 bn6.3%
5 to 10 ml30.0%30.0%USD 6.4 bn6.5%
Above 10 ml14.0%15.0%USD 3.0 bn7.2%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Polypropylene76.0%73.0%USD 16.1 bn6.1%
Other plastics12.0%12.0%USD 2.5 bn6.5%
Glass12.0%15.0%USD 2.5 bn8.9%

By buyer

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals44.0%42.0%USD 9.3 bn6.0%
Mass vaccination22.0%22.0%USD 4.7 bn6.5%
Clinics and pharmacies20.0%22.0%USD 4.2 bn7.5%
Home14.0%14.0%USD 3.0 bn6.5%

Top 25 countries for syringe by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 69.5% of 2026 revenue and the 25 countries below together hold 90.9%.

Exhibit 4United States is the largest country market at USD 5.1 bn in 2026, and the three largest countries hold 45.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Syringe market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 5.1 bn, 24.0%; China: USD 3.0 bn, 14.0%; India: USD 1.5 bn, 7.0%; Japan: USD 1.1 bn, 5.0%; Germany: USD 1.1 bn, 5.0%; Brazil: USD 742 mn, 3.5%; France: USD 742 mn, 3.5%; United Kingdom: USD 636 mn, 3.0%; Italy: USD 530 mn, 2.5%; Indonesia: USD 424 mn, 2.0%.United States5.1 bn 24.0%China3.0 bn 14.0%India1.5 bn 7.0%Japan1.1 bn 5.0%Germany1.1 bn 5.0%Brazil742 mn 3.5%France742 mn 3.5%United Kingdom636 mn 3.0%Italy530 mn 2.5%Indonesia424 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 5.1 bn24.0%USD 8.8 bn5.6%
2ChinaUSD 3.0 bn14.0%USD 6.5 bn8.1%
3IndiaUSD 1.5 bn7.0%USD 3.5 bn9.1%
4JapanUSD 1.1 bn5.0%USD 1.6 bn4.2%
5GermanyUSD 1.1 bn5.0%USD 1.8 bn5.2%
6BrazilUSD 742 mn3.5%USD 1.4 bn6.5%
7FranceUSD 742 mn3.5%USD 1.2 bn5.2%
8United KingdomUSD 636 mn3.0%USD 1.0 bn5.0%
9ItalyUSD 530 mn2.5%USD 836 mn4.7%
10IndonesiaUSD 424 mn2.0%USD 915 mn8.0%
11MexicoUSD 411 mn1.9%USD 772 mn6.5%
12SpainUSD 411 mn1.9%USD 772 mn6.5%
13RussiaUSD 411 mn1.9%USD 772 mn6.5%
14TurkeyUSD 411 mn1.9%USD 772 mn6.5%
15PakistanUSD 409 mn1.9%USD 772 mn6.6%
16PolandUSD 356 mn1.7%USD 764 mn7.9%
17Saudi ArabiaUSD 318 mn1.5%USD 680 mn7.9%
18EgyptUSD 286 mn1.4%USD 617 mn8.0%
19ThailandUSD 263 mn1.2%USD 565 mn8.0%
20ArgentinaUSD 244 mn1.1%USD 521 mn7.9%
21CanadaUSD 227 mn1.1%USD 342 mn4.2%
22VietnamUSD 212 mn1.0%USD 454 mn7.9%
23BangladeshUSD 199 mn0.9%USD 430 mn8.0%
24NetherlandsUSD 189 mn0.9%USD 287 mn4.3%
25ChileUSD 180 mn0.8%USD 306 mn5.5%
Rest of worldUSD 1.9 bn9.1%USD 3.4 bn5.9%
Exhibit 5United States and China account for 39% of the USD 18.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Syringe market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 21.2 bn. United States: +USD 3.7 bn; China: +USD 3.5 bn; India: +USD 2.1 bn; Germany: +USD 691 mn; Brazil: +USD 651 mn; 20 other countries: +USD 6.5 bn; Rest of world: +USD 1.5 bn. Market value 2036: USD 39.8 bn.Market value 202621.2 bnUnited States+3.7 bnChina+3.5 bnIndia+2.1 bnGermany+691 mnBrazil+651 mn20 other countries+6.5 bnRest of world+1.5 bnMarket value 203639.8 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • BD
  • Terumo
  • Nipro
  • B. Braun
  • Gerresheimer
  • SCHOTT Pharma
  • Cardinal Health

Group 2: Regional and specialist players

  • Retractable Technologies
  • Ypsomed
  • Weigao
  • Hindustan Syringes & Medical Devices
  • Stevanato Group
  • Zhejiang Kindly Medical Devices
  • Poly Medicure
  • HTL-Strefa
  • Medefil
  • Henke-Sass Wolf

Group 3: Emerging and niche players

  • Sol-Millennium
  • UltiMed
  • Narang Medical
  • Jiangxi Hongda Medical Equipment
  • Advin Health Care

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the syringe market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.

The market is divided by product, by application, by size, by material, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the syringe market?

The global syringe market is estimated at USD 20.0 bn in 2025 and USD 21.2 bn in 2026.

How fast will the syringe market grow?

It is forecast to reach USD 39.8 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 18.6 bn.

Which country is the largest market for syringe?

United States is the largest market by revenue at USD 5.1 bn in 2026, 24.0% of the global total. The three largest countries together hold 45.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.1% a year from 2026 to 2036.

Which syringe segment is largest?

In the by product split, Conventional disposable is the largest segment with 40.0% of 2026 revenue.

Who are the leading syringe companies?

Global leaders include BD, Terumo, Nipro, B. Braun.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Synthetic Clinical Trial Data Tablet →

All Healthcare markets →

Request a sample